Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma (Q88405532)
Jump to navigation
Jump to search
scientific article published on 01 April 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma |
scientific article published on 01 April 2018 |
Statements
Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma (English)